膜性肾病的诊断

doi:10.16150/j.1671-2870.2017.04.002

摘要/Abstract

中图分类号:

R692.3⁺9

李贵森. 膜性肾病的诊断[J]. 诊断学理论与实践, 2017, 16(04): 353-357.

[1] Xu X, Wang G, Chen N, et al.Long-term exposure to air pollution and increased risk of membranous nephropathy in China[J]. J Am Soc Nephrol,2016,27(12):3739-3746.
[2] Stanescu HC, Arcos-Burgos M, Medlar A, et al.Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy[J]. N Engl J Med,2011,364(7):616-626.
[3] Lv J, Hou W, Zhou X, et al.Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy[J]. J Am Soc Nephrol,2013,24(8):1323-1329.
[4] Honkanen E, Törnroth T, Grönhagen-Riska C. Natural history, clinical course and morphological evolution of membranous nephropathy[J]. Nephrol Dial Transplant,1992,7 Suppl 1:35-41.
[5] Lionaki S, Derebail VK, Hogan SL, et al.Venous thromboembolism in patients with membranous nephropathy[J]. Clin J Am Soc Nephrol,2012,7(1):43-51.
[6] Tomas NM, Beck LH Jr, Meyer-Schwesinger C, et al.Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy[J]. N Engl J Med, 2014, 371(24):2277-2287.
[7] Beck LH Jr, Bonegio RG, Lambeau G, et al.M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy[J]. N Engl J Med,2009,361(1):11-21.
[8] De Vriese AS, Glassock RJ, Nath KA, et al.A Proposal for a serology-based approach to membranous nephropathy[J]. J Am Soc Nephrol,2017,28(2):421-430.
[9] Timmermans SA, Damoiseaux JG, Heerings-Rewinkel PT, et al.Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: a cohort study[J]. Am J Clin Pathol,2014,142(1):29-34.
[10] Du Y, Li J, He F, et al.The diagnosis accuracy of PLA2R-AB in the diagnosis of idiopathic membranous nephropathy: a meta-analysis[J]. PLoS One,2014,9(8): e104936.
[11] Dai H, Zhang H, He Y.Diagnostic accuracy of PLA2R autoantibodies and glomerular staining for the differentiation of idiopathic and secondary membranous nephropathy: an updated meta-analysis[J]. Sci Rep, 2015, 5: 8803.
[12] Hoxha E, Beck LH Jr, Wiech T, et al.An Indirect immunofluorescence method facilitates detection of thrombospondin type 1 domain-containing 7A-specific antibo-dies in membranous nephropathy[J]. J Am Soc Nephrol,2017,28(2):520-531.
[13] Hoxha E, Wiech T, Stahl PR, et al.A Mechanism for Cancer-Associated Membranous Nephropathy[J]. N Engl J Med,2016,374(20):1995-1996.
[14] Stahl PR, Hoxha E, Wiech T, et al.THSD7A expression in human cancer[J]. Genes Chromosomes Cancer,2017, 56(4):314-327.
[15] Hofstra JM, Beck LH Jr, Beck DM, et al.Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy[J]. Clin J Am Soc Nephrol,2011,6(6):1286-1291.
[16] Quintana LF, Blasco M, Seras M, et al.Antiphospholipase A2 receptor antibody levels predict the risk of posttransplantation recurrence of membranous nephropathy[J]. Transplantation, 2015, 99(8):1709-1714.
[17] Tomas NM, Hoxha E, Reinicke AT, et al.Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy[J]. J Clin Invest,2016, 126(7):2519-2532.
[18] Pei Y, Cattran D, Greenwood C.Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis[J]. Kidney Int,1992,42(4):960-966.
[19] Tse WY, Howie AJ, Adu D, et al.Association of vasculitic glomerulonephritis with membranous nephropathy: a report of 10 cases[J]. Nephrol Dial Transplant,1997,12(5):1017-1027.
[20] Nasr SH, Said SM, Valeri AM, et al.Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis[J]. Clin J Am Soc Nephrol, 2009,4(2):299-308.
[21] Lefaucheur C, Stengel B, Nochy D, et al.Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association[J]. Kidney Int, 2006,70(8):1510-1517.

膜性肾病的诊断

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	何亲羽, 王伟, 陈立芬, 张雪蕾, 董治亚. LHCGR基因突变致家族性男性性早熟2例报告及文献复习[J]. 诊断学理论与实践, 2022, 21(05): 598-605.
[2]	陈志敏, 何浩岚. 艾滋病合并马尔尼菲篮状菌病的诊治现状[J]. 诊断学理论与实践, 2022, 21(04): 425-430.
[3]	沈银忠. 《人类免疫缺陷病毒感染/艾滋病合并结核分枝杆菌感染诊治专家共识》解读[J]. 诊断学理论与实践, 2022, 21(04): 431-436.
[4]	陈宏, 沈银忠. 人类免疫缺陷病毒感染/艾滋病合并结核病的诊治进展[J]. 诊断学理论与实践, 2022, 21(04): 530-534.
[5]	何新, 陈慧, 冯炜炜. 机器学习算法在辅助超声诊断附件肿块良恶性中的应用研究进展[J]. 诊断学理论与实践, 2022, 21(04): 541-546.
[6]	徐子真, 李擎天, 刘湘帆, 李莉, 李惠, 王也飞, 吴洁敏, 陈宁, 梁璆荔, 陈松立, 戴健敏, 宋珍, 丁磊. 实验诊断学在线课程的建立和实践[J]. 诊断学理论与实践, 2022, 21(04): 547-550.
[7]	汤建平, 龚邦东. 干燥综合征的诊治现状、挑战和思考[J]. 诊断学理论与实践, 2022, 21(03): 291-298.
[8]	赵然, 詹维伟, 侯怡卿. 计算机辅助诊断系统辅助超声诊断甲状腺弥漫性病变合并结节良恶性的应用价值[J]. 诊断学理论与实践, 2022, 21(03): 390-394.
[9]	郭业兵, 郑金峰. 阴道壁胃肠道外间质瘤一例报道并文献复习[J]. 诊断学理论与实践, 2022, 21(03): 405-407.
[10]	王刚, 陈生弟. 神经病学的诊断：起源、发展及挑战[J]. 诊断学理论与实践, 2022, 21(01): 1-4.
[11]	唐静仪, 余群, 刘军. 结合人工智能的结构影像分析对阿尔茨海默病的早期预测及精准诊断研究进展[J]. 诊断学理论与实践, 2022, 21(01): 12-17.
[12]	魏文石. 直面我国阿尔茨海默病诊治的挑战——《中国阿尔茨海默病报告2021》解读[J]. 诊断学理论与实践, 2022, 21(01): 5-7.
[13]	王蔚, 王小钦. 缺铁性贫血的病因诊断[J]. 诊断学理论与实践, 2021, 20(06): 529-532.
[14]	岳婧婧, 宋琦, 江旭峰, 王黎, 赵维莅, 严福华. 磁共振全身扩散加权成像结合T2WI抑脂序列与FDG-PET/CT在初发淋巴瘤分期及病灶检出的对比研究[J]. 诊断学理论与实践, 2021, 20(06): 540-546.
[15]	王昭晖, 吴海波. 胃神经鞘瘤31例临床病理学分析[J]. 诊断学理论与实践, 2021, 20(06): 552-556.